Abstract

TRIVI, MARCELO et al. Prospective Registry of Antithrombotic Therapy in Acute Coronary Syndromes (EPICOR). Rev. argent. cardiol. [online]. 2019, vol.87, n.1, pp.7-10. ISSN 1850-3748.

Objectives: To present the two-year follow-up resultis of the EPICOR study Argentine cohort, a prospective, international, observational, multicenter registry designed to determine the use of antithrombotic therapy patterns in the routine clinical practice of patientis with acute coronary syndrome (ACS).

Methods: The study enrolled a total of 438 consecutive patientis with ST-segment elevation myocardial infarction (STEMI, 41%) or non-ST-segment elevation ACS (NSTE ACS, 59%) discharged alive from public, private, and community hospitals. Mean age was 62 years, 76% of patientis were male, 71% hypertensive, 64% smokers, 19% diabetic and 40% had history of previous cardiovascular disease.

Resultis: Overall mortality was 4.8% at 1 year and 7.3% at 2 years. Use of dual antiplatelet therapy was 80% at one year and 53% at 2 years (p<0.0001), with no differences between those with or without ST-segment elevation. The 2-year incidence of ischemic and major bleeding eventis was 15.3% and 1.8%, respectively

Conclusions: Beyond the one-year administration recommended by the guidelines, a high percentage of persistent dual antiplatelet therapy was observed at 2 years, with a low incidence of major bleeding eventis, suggesting a clinical risk-benefit selection.

Keywords : Registry ,Acute Coronary Syndrome; Myocardial Infarction; Antithrombotic Treatment; Long-term Follow up - Mortality.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )